GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cardiff Oncology Inc (FRA:XE7C) » Definitions » Dividend Yield %

Cardiff Oncology (FRA:XE7C) Dividend Yield % : 0.00% (As of Apr. 05, 2025)


View and export this data going back to 1997. Start your Free Trial

What is Cardiff Oncology Dividend Yield %?

As of today (2025-04-05), the Trailing Annual Dividend Yield of Cardiff Oncology is 0.00%.

The historical rank and industry rank for Cardiff Oncology's Dividend Yield % or its related term are showing as below:

FRA:XE7C's Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.46
* Ranked among companies with meaningful Dividend Yield % only.

Cardiff Oncology's Dividend Payout Ratio for the three months ended in Dec. 2024 was 0.00.

As of today (2025-04-05), the Forward Dividend Yield % of Cardiff Oncology is 0.00%.

Cardiff Oncology's Dividends per Share for the three months ended in Dec. 2024 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Cardiff Oncology Dividend Yield % Historical Data

The historical data trend for Cardiff Oncology's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiff Oncology Dividend Yield % Chart

Cardiff Oncology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Dividend Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cardiff Oncology Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cardiff Oncology's Dividend Yield %

For the Biotechnology subindustry, Cardiff Oncology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cardiff Oncology's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cardiff Oncology's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cardiff Oncology's Dividend Yield % falls into.


;
;

Cardiff Oncology Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.


Cardiff Oncology  (FRA:XE7C) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Cardiff Oncology Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Cardiff Oncology's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cardiff Oncology Business Description

Traded in Other Exchanges
Address
11055 Flintkote Avenue, San Diego, CA, USA, 92121
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Cardiff Oncology Headlines

No Headlines